Stock NKGN NKGEN BIOTECH, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart NKGen Biotech, Inc. Nyse

Equities

NKGN

US65488A1016

Market Closed - Nyse
Other stock markets
 01:30:00 01/06/2024 am IST 		5-day change 1st Jan Change
1.67 USD +6.37% Intraday chart for NKGen Biotech, Inc. +17.61% -79.88%
23/05 NKGen Biotech Publishes Phase 1 Interim Analysis Results of SNK02 Allogeneic NK Cell Therapy in Advanced Solid Tumors at the 2024 American Society of Clinical Oncology Annual Meeting CI
20/05 NKGen Biotech, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Other Biotechnology & Medical Research

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
MODERNA, INC. Stock Moderna, Inc.
 54.64B -
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
 39.92B
LONZA GROUP AG Stock Lonza Group AG
 38.82B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
 26.86B
CELLTRION, INC. Stock Celltrion, Inc.
 26.22B
  1. Stock Market
  2. Equities
  3. NKGN Stock
  4. NKGN Stock
  5. Charts NKGen Biotech, Inc.
  6. Sector Chart